225 related articles for article (PubMed ID: 33573453)
21. High intensity focused ultrasound ablation for submucosal fibroids: A comparison between type I and type II.
Xie B; Zhang C; Xiong C; He J; Huang G; Zhang L
Int J Hyperthermia; 2015; 31(6):593-9. PubMed ID: 26044873
[TBL] [Abstract][Full Text] [Related]
22. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
23. Post treatment and 3 month contrast enhanced MRI findings following HIFU of submucosal fibroids: a retrospective study.
Xu J; Tang W; Lin L; Wang Y; Cheng J
Int J Hyperthermia; 2023; 40(1):2216897. PubMed ID: 37230470
[TBL] [Abstract][Full Text] [Related]
24. Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis.
Kamath MS; Kalampokas EE; Kalampokas TE
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():11-8. PubMed ID: 24702901
[TBL] [Abstract][Full Text] [Related]
25. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study.
Liu X; Tang J; Luo Y; Wang Y; Song L; Wang W
BJOG; 2020 Oct; 127(11):1422-1428. PubMed ID: 32285586
[TBL] [Abstract][Full Text] [Related]
26. 500 Cases of High-intensity Focused Ultrasound (HIFU) Ablated Uterine Fibroids and Adenomyosis.
Jeng CJ; Ou KY; Long CY; Chuang L; Ker CR
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):865-871. PubMed ID: 33218403
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T
Yang S; Kong F; Hou R; Rong F; Ma N; Li S; Yang J
Br J Radiol; 2017 May; 90(1073):20160760. PubMed ID: 28256923
[TBL] [Abstract][Full Text] [Related]
28. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of single-dose gonadotropin-releasing hormone agonist administration prior to magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroids.
Park H; Yoon SW
Radiol Med; 2017 Aug; 122(8):611-616. PubMed ID: 28341966
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound guidance during hysteroscopic myomectomy in G1 and G2 Submucous Myomas: for a safer one step surgery.
Korkmazer E; Tekin B; Solak N
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():108-11. PubMed ID: 27267872
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience.
Cheung VYT; Lam TPW; Jenkins CR; Lam SW; Cheung GKI; Chan SSY; Choi WK
J Obstet Gynaecol; 2019 Aug; 39(6):833-839. PubMed ID: 31006301
[TBL] [Abstract][Full Text] [Related]
33. The effect of exercise on high-intensity focused ultrasound treatment efficacy in uterine fibroids and adenomyosis: a retrospective study.
Huang X; Yu D; Zou M; Wang L; Xing HR; Wang Z
BJOG; 2017 Aug; 124 Suppl 3():46-52. PubMed ID: 28856860
[TBL] [Abstract][Full Text] [Related]
34. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
35. High-intensity focused ultrasound and laparoscopic myomectomy in the treatment of uterine fibroids: a comparative study.
Liu Y; Ran W; Shen Y; Feng W; Yi J
BJOG; 2017 Aug; 124 Suppl 3():36-39. PubMed ID: 28856854
[TBL] [Abstract][Full Text] [Related]
36. Letrozole as premedication of high intensity focused ultrasound treatment of uterine fibroids: A retrospective observation study.
Chen WC; Hsu CC; Huang HJ; Cheng WJ; Chang TC; Chou HH
Front Med (Lausanne); 2022; 9():1069654. PubMed ID: 36561715
[TBL] [Abstract][Full Text] [Related]
37. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids.
Kim YS; Kim TJ; Lim HK; Rhim H; Jung SH; Ahn JH; Lee JW; Kim BG
Eur Radiol; 2017 Sep; 27(9):3956-3965. PubMed ID: 28210800
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of focused ultrasound ablation in treatment of submucosal uterine fibroids].
Wang T; Wang W; Chen WZ; Wang YX; Ye HY; Tang J
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):407-11. PubMed ID: 21781578
[TBL] [Abstract][Full Text] [Related]
40. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice.
Ruhnke H; Eckey T; Bohlmann MK; Beldoch MP; Neumann A; Agic A; Hägele J; Diedrich K; Barkhausen J; Hunold P
Rofo; 2013 Sep; 184(10):983-91. PubMed ID: 23884908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
